Parkin has been shown to downregulate HIF1A via proteasomal degradation in breast cancer leading to inhibition of its metastasis [153], and similarly Parkin has been reported to downregulate HIF1A while upregulating HIF3A in GBM [154]. Here, HIF1A is linked to breast carcinoma.